Sample - Global in Vitro Diagnostics (IVD) Market To 2025 PDF

GLOBAL IN VITRO DIAGNOSTICS
(IVD) MARKET TO 2025
Growth Opportunities, Competition, Trends And

OGAMVCM108
Outlook Report
“2019 Future Of Global In Vitro Diagnostics (IVD) Market Outlook to 2025- Growth Opportunities,
Competition And Outlook of In Vitro Diagnostics (IVD) Across Product, Applications, End-User Industry
And Regions” is part of the series of our 300+ Health Care market analysis reports. It offers an in-
depth analysis of the In Vitro Diagnostics (IVD) market at global, regional and country level across
types and applications. Major Macro, Micro Trends, Developments and Factors Shaping the Future
are analyzed. Competition, company profiles and developments of leading players are offered.
GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET TO 2025
GLOBAL IN VITRO DIAGNOSTICS (IVD)

MARKET TO 2025 Analysis Included
OGAnalysis has been analyzing the In Vitro Diagnostics (IVD) market for Frequency, Time Period
over 8 years and this report includes future trends, analysis and insights
- Base year Data for 2018
together with updated outlook for the global and regional In Vitro
Diagnostics (IVD) market every six months. The report highlights the - Five Year Annual Forecast, 2019- 2025
potential opportunities and challenges that In Vitro Diagnostics (IVD)
suppliers face and presents actionable insights through critical data on - Updated on Half yearly Basis
the competitive market.
Metrics
- Revenues ($)
The research work includes over 90 data tables and charts prepared
based on data in our proprietary databases, which is collected from - Prices
leading manufacturers and government statistics to ensure reliable
-Volume
market data. It also presents the critical analysis of end-user industries
along with internal and external factors affecting the market.
Market Segmentation
- By Region (Asia Pacific, Europe, North
America, Middle East Africa, South and
Central America)
Global In Vitro Diagnostics (IVD)Market Outlook
- By Product Type (Instruments, Reagents,
Software, Services)
- BY Test Type (Immunoassays, Blood

Glucose, Monitoring, Clinical Chemistry,
Molecular Diagnostics, Microbiology,
Anatomic Pathology, Hematology,
Coagulation, Critical Care, Urinalysis, Others)
- By Application (Infectious disease,

Diabetics, Oncology, Cardiology,
Source: OGAnalysis
Nephrology, Autoimmune diseases, Drug
testing, HIV/Aids, Women Health, Others)
-By End User Industry (Hospital, Clinics, Point

of Care, Educational Institutions, Others)
No portion of this report may be reproduced, reused, or otherwise distributed in any form without prior written
consent from OGAnalysis (www.oganalysis.com) Page 1
1. GLOBALIN VITRO DIAGNOSTICS (IVD) INDUSTRY

1.1. Market Scope and Definition
MARKET
By Test Type
By Product Type
Immunoassays
Instruments Blood Glucose

Monitoring
Reagants
Clinical
Chemistry
Softwares Molecular
Diagnostics
Microbiology
Services
Anatomic
Pathology
Haemotology
Coagulation
Critical Care
Urinalysis
Others
No portion of this report may be reproduced, reused, or otherwise distributed in any form without prior
written consent from OGAnalysis (www.oganalysis.com) Page 2

MARKET
By Application By End User
Diabetics
Hospitals
Infectious
Diseases
Clinics
Oncology
Cardiology
Point of Care
Nephrology
Educational
Autoimmune Instutuions
Diseases
Drug Testing Others
HIV/Aids
Women
Health
Others
GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET
BY GEOGRAPHY
North Middle East South

Europe Asia Pacific Africa Central
America America
USA Germany China Middle East Argentina
Canada UK South Korea Africa Brazil
Mexico France Japan Rest of South

Central
America
Spain India
Rest of Asia
Russia
Pacific
Rest of
Europe
2. EXECUTIVE SUMMARY
Global In Vitro Diagnostics (IVD) Market Valued at $52.9

Billion During 2018
Market is Outlook to witness 5.43% CAGR Growth over

the Forecast Period
Asia Pacific stood the Most Attractive Market Worldwide

with 23% Share in 2018
India market will Surpass XX market driven by growth in

demand
Increasing number of Companies opting for Inorganic

Growth through M&A
Key Trend Set to the Shape the Future of Industry

includes surge towards Advanced Technology Products
Widening Scope of End User Markets with New uses in

areas of Point of Care and Oncology areas observed
Top performing Type as of 2018 is Infectious Diseases
.Figure 1: Global In Vitro Diagnostics (IVD) Company Market Share (%)
Source: OGAnalysis
Healthcare industry has witnessed a significant growth over the past decade with the development of
the IVD market. IVD continues to remain the dominant market in the global medical devices market
accounting for 13% of the total medical devices market in 2018. Although there are various
opportunities for the growth of the market, regulatory challenges, reimbursement pressure, challenges
in health care budgets, and advancement of low cost providers are some of the limitations for the
market growth. Regulatory bodies are now focusing on having evidence based approval process for
high end diagnostics through patient treatment.
Companies in the IVD industry are focusing on developing Companion Diagnostics and Molecular
Diagnostics products, as this market are having the high potential for growth.
In 2018, IVD segment has witnessed the highest number of M&A deals in the medical devices market.
More than half of the deals in the IVD segment are in the Molecular Diagnostics market. Companies
are focusing on increasing their existing product portfolio and in strengthening their product pipelines.
IVD manufactures are highly focused on acquiring early stage Molecular Diagnostics companies
focusing on novel technologies. With limited differentiation in the product offerings, companies with
greater economies of scale will have higher competitive advantage over pricing.
The IVD market remains attractive for low cost providers especially in the emerging market such as
Asia-Pacific and South American countries. Growing regulatory challenges in United States and
European regions will be restricting the entry of the low-cost manufactures into these markets.
Companies with high cash are entering the market through strategic partnerships and acquisitions.
Entry of new companies and acquisitions of companies focusing on novel technologies are leading to
innovations across geographies.
Significant rise in health expenditure, availability of medical coverage, aging population and willing
to pay among the consumers are the key trends that are accelerating growth of IVD market across
APAC region. Increase in GDP rate and per capita income is fuelling the investments for the growth of
healthcare infrastructure and increased healthcare access. Emerging of latest technologies and launch
of innovative products by the key players across Asia Pacific region is incurring the growth
opportunities.
Increased health awareness among the customers and government support to awareness among the
customers regarding home healthcare diagnostics such as blood pressure monitoring and others are
attributing for the market growth. Presence of weak healthcare infrastructure offered by
governments and public organizations are contributing for the growth of home healthcare solutions.
Emerging markets across APAC region consists of large populations are attributed for a lot of
opportunities to help the ageing population for achieving the better quality of life and healthy
ageing.
Germany
Increase in prevalence of chronic and infectious diseases coupled with rise in geriatric population in
Germany is boosting the growth of IVD market. Furthermore, growth in trend toward personalized
medicine and technological advancement include metabolic and protein analysis in the IVD devices
has increased the IVD market growth in this region.
Additionally, advert point of care diagnosis is projected to drive the market growth. Ongoing R&D
activities related to IVD are anticipated to present new opportunities for the market and also
increase in awareness of preventive healthcare measures provides huge growth potential for IVD
market.
The clinical diagnostics have become essential part of healthcare, as the technologies advance.
Widening of technological developments to enhance the efficiency of IVD, increase outsourcing of
laboratories in Germany region drive the market growth.
In addition, the shift to new sensor-based technologies for the measurement of glucose continues in
Germany.
Rise in disposable income and awareness of preventive diagnosis & treatment among the population
is expected to increase the market growth over the upcoming years.
First, the restrictive legal framework that forces medical doctors to prescribe generic, low-priced test
strips to not overstep their respective budget remains in place.
Stringent government regulations are anticipated to impede the growth of IVD market. Widening of
R&D activities to IVD is expected to present new opportunities for the growth of IVD market.
3. STRATEGIC ANALYSIS REVIEW
3.1. Por ter’s Five Forces Analysis
Industry Attractiveness Index – 2018(Sample Graph)
Source: OGAnalysis
4. GLOBAL OUTLOOK AND GROWTH OPPORTUNITIES
4.1. Key Product Type of In Vitro Diagnostics (IVD) Market, 2017- 2025
Table 1: Global In Vitro Diagnostics (IVD)Market Value by Product Type, $ Million, 2017-2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Instruments XX XX XX XX XX XX XX XX XX XX%
Reagents XX XX XX XX XX XX XX XX XX XX%
Software XX XX XX XX XX XX XX XX XX XX%
Services XX XX XX XX XX XX XX XX XX XX%
Total XX XX XX XX XX XX XX XX XX XX%
Source: OGAnalysis
TEXT REDACTED IN SAMPLE VIEW
4.1.1. Instruments
Figure 2: Global IVD InstrumentsMarket Value Outlook, $Million, 2017-2025
35
30
25
20
15
10
0
2017 2018 2019 2020 2021 2022 2023 2024 2025
Source: OGAnalysis
4.1.2. Reagents
Figure 3: Global IVD ReagentsMarket Value Outlook, $Million, 2017-2025
35
30
25
20
15
10
0
2017 2018 2019 2020 2021 2022 2023 2024 2025
Source: OGAnalysis
4.2. Key Test Types of In Vitro Diagnostics (IVD) Market, 2017- 2025
Table 2: Global In Vitro Diagnostics (IVD) Market Value by Test Type, $Million, 2017-2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Immunoassays Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Blood Glucose Monitoring Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Clinical Chemistry Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Molecular Diagnostics Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Microbiology Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Anatomic Pathology Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Haematology Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Coagulation Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Critical Care Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Urinalysis Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Others Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Total Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Source: OGAnalysis
4.2.1. Immunoassays
Figure 4: Global Immunoassays In Vitro Diagnostics (IVD)Market Value Outlook, $Million,

2017-2025
35
30
25
20
15
10
0
2017 2018 2019 2020 2021 2022 2023 2024 2025
Source: OGAnalysis
4.3. Key Applications of In Vitro Diagnostics (IVD) Market, 2017- 2025
Table 3: Global In Vitro Diagnostics (IVD) Market Value by Application, $Million, 2017-2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Diabetics Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Infectious Diseases Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Oncology Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Cardiology Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Nephrology Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Autoimmune Diseases Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Drug Testing Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
HIV/Aids Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Women Health Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Source: OGAnalysis
4.3.1. Diabetics
Figure 5: Global Diabetics In Vitro Diagnostics (IVD)Market Value Outlook, $Million, 2017-2025
35
30
25
20
15
10
0
2017 2018 2019 2020 2021 2022 2023 2024 2025
Source: OGAnalysis
4.4. Key End User Industry of In Vitro Diagnostics (IVD) Market, 2017-
2025
Table 4: Global In Vitro Diagnostics (IVD) Market Value by End User Industry, $Million, 2017-
2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Hospitals Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Clinics Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Point of Care Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Educational Institutions Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Source: OGAnalysis
4.4.1. Hospitals
Figure 6: Global Hospitals In Vitro Diagnostics (IVD)Market Value Outlook, $Million, 2017-2025
35
30
25
20
15
10
0
2017 2018 2019 2020 2021 2022 2023 2024 2025
Source: OGAnalysis
4.5. In Vitro Diagnostics (IVD) Market Analysis by Geography, 2017-
2025
Table 5: Global In Vitro Diagnostics (IVD)Market Value by Region, $Million, 2017-2025
CAGR
2017 2018 2019 2020 2021 2022 2023 2024 2025
(%)
North America Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Europe Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Asia-Pacific Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Middle East Africa Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
South Central America Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Source: OGAnalysis
Figure 7: Global In Vitro Diagnostics (IVD) Market Growth By Regions, 2018-2025 (Sample
Data)
Bubble size indicates the 2018 market value ($millions)

Source: OGAnalysis
SAMPLE ILLUSTRATION
5. NORTH AMERICA OUTLOOK AND GROWTH OPPORTUNITIES
5.1. Introduction
Table 6: North America In Vitro Diagnostics (IVD)- Market Snapshot, 2018
Parameter Value
Market Value- $ Million 21,781.8
Market Growth (2019- 2025)- % 4.95
Share in Global Value- % Xx
Leading Country United States
Largest Product Type Reagents
Leading Test Type Immunoassays
Prominent Application Infectious Diseases
Largest End User Industry Hospitals
Source: OGAnalysis
North America is the Xx largest market for the In Vitro Diagnostics (IVD) with US leading the market.
North America is poised at CAGR of 4.95% during the forecast period 2019 to 2025 with the initial
market value of $ 22,954.9 million in 2019 that is expected to project a final market value of $
30,670.3 million by 2025.
Key factors shaping the future of North American demand include-
5.2. Nor th America In Vitro Diagnostics (IVD) Market Outlook by Product
Type, 2017- 2025
Table 7: North America In Vitro Diagnostics (IVD) Market Value by Product Type, $ Million,
2017-2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Instruments 4,576.0 XX XX XX XX XX XX XX XX 4.14%
Reagents 13,789.9 XX XX XX XX XX XX XX XX 4.55%
Software 794.3 XX XX XX XX XX XX XX XX 10.61%
Services 1,471.0 XX XX XX XX XX XX XX XX 7.30%
Total XX XX XX XX XX XX XX XX XX 4.95%
Source: OGAnalysis
5.3. Nor th America In Vitro Diagnostics (IVD) Market Outlook by Test
Type, 2017- 2025
Table 8: North America In Vitro Diagnostics (IVD) Market Value by Test Type, $Million, 2017-
2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Immunoassays 6,289.9 Xx Xx Xx Xx Xx Xx Xx Xx 5.86%
Blood Glucose Monitoring 2,280.0 Xx Xx Xx Xx Xx Xx Xx Xx 3.04%
Clinical Chemistry 3,619.6 Xx Xx Xx Xx Xx Xx Xx Xx 3.23%
Molecular Diagnostics 2,557.2 Xx Xx Xx Xx Xx Xx Xx Xx 6.57%
Microbiology 1,213.5 Xx Xx Xx Xx Xx Xx Xx Xx 5.57%
Anatomic Pathology 1,102.0 Xx Xx Xx Xx Xx Xx Xx Xx 3.42%
Haematology 1,222.4 Xx Xx Xx Xx Xx Xx Xx Xx 4.61%
Coagulation 790.9 Xx Xx Xx Xx Xx Xx Xx Xx 5.77%
Critical Care 520.5 Xx Xx Xx Xx Xx Xx Xx Xx 6.61%
Urinalysis 338.9 Xx Xx Xx Xx Xx Xx Xx Xx 4.10%
Others 696.3 Xx Xx Xx Xx Xx Xx Xx Xx 3.91%
Source: OGAnalysis
5.4. Nor th America In Vitro Diagnostics (IVD) Market Outlook by
Application, 2017- 2025
Table 9: North America In Vitro Diagnostics (IVD) Market Value by Application, $Million, 2017-
2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Diabetics 2,125.0 5.28%
Infectious Diseases 5,570.4 3.80%
Oncology 2,888.4 6.63%
Cardiology 3,919.9 5.36%
Nephrology 618.9 5.24%
Autoimmune Diseases 2,269.4 5.42%
Drug Testing 701.5 4.43%
HIV/Aids 330.1 5.16%
Women Health 577.7 5.86%
Others 1,629.9 3.07%
Total 20,631.1 Xx
Source: OGAnalysis
5.5. Nor th America In Vitro Diagnostics (IVD) Market Outlook by End
User Industry, 2017- 2025
Table 10: North America In Vitro Diagnostics (IVD) Market Value by End User Industry, $Million,
2017-2025
2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR (%)
Hospitals Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Clinics Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Point of Care Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Educational Institutions Xx Xx Xx Xx Xx Xx Xx Xx Xx Xx
Source: OGAnalysis
5.5.1. United States
.Figure 8: United States: In Vitro Diagnostics (IVD)Market Value, $Million, 2017-2025
Source: OGAnalysis
Companies analyzed in this report include-
Roche Diagnostics
Abbott Laboratories, Inc.
Danaher Corporation
Siemens AG
Thermo Fisher Scientific
Becton, Dickinson and Company
Sysmex Corporation
Biomerieux SA
Ortho Clinical Diagnostics
Exact Sciences
Roche Diagnostics
Table 11: Roche Diagnostics - Key Snapshot
Parameter Value
Company Legal Name
Establishment/Incorporation (in Year)
Company is Based and Registered in
Phone No.
Fax No.
Website
Operating Regions
Business Lines
Chairman of the Board
Corporate/ Registered Address
Source: OGAnalysis
Business Overview:
Key products:
Financial Analysis
Key Indicators:
Roche Diagnostics -Key Indicators, $Million
Parameter(In $millions) Value

Sales
Underlying Trading operating profit
as % of sales
Trading operating profit
as % of sales
Profit for the year attributable to shareholders of the parent (Net profit)
as % of sales
Equity attributable to shareholders of the parent
Net financial debt
Ratio of net financial debt to equity (gearing)
Operating cash flow
as % of net financial debt
Free cash flow
Capital expenditure
Source: OGAnalysis
Key Ratios:
Roche Diagnostics -Key Ratios
Parameter Dec-2017 Dec-2016 Dec-2015 Dec-2014

Profitability
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
Financial Strength
Current Ratio
Long-Term Debt/Equity
Total Debt/Equity
Interest Coverage
Management Effectiveness
Return on Assets
Return on Equity
Efficiency
Receivables Turnover
Inventory Turnover
Asset Turnover
Source: OGAnalysis
RECENT DEVELOPMENTS
Agreements, Par tnerships, Collaborations and Joint Ventures
February -XX
Xx
November-2018
Xx
Aug-XX
Xx
April-Xx
Xx
Mergers & Acquisitions
July -XX
Xx
September-XX
Xx
June-XX
Xx
April-2018
Xx
New Product Launch
November -2018
Xx
August-2018
Xx
June-XX
Xx
May-XX
Xx
Other Key Developments
October -XX
Xx
September-XX
Xx
APPENDIX
About Us
OGAnalysis is the leading brand registered under MARRA Research and Analysis Pvt Ltd-
established in January 2011, and is one of the globally reputed market research players with strong
expertise across 12 sectors. Currently, we publish over 4,000 country and regional reports and over
10,000 company profiles and market them through our established distribution channels.
OGANALYSIS has served over 900 clients worldwide. The company is well known for the quality of
information and research depth in all its publications. Our forecasts are also considered as highly
reliable in the research industry.
PRODUCTS AND SERVICES OFFERED

Database Driven Information and analytical Reports
 Country and Regional Market Intelligence Reports

 Analytical Multi-Client Studies
 Customized consulting services
 Company SWOT and Strategic Analysis Reports
 Infrastructure Reports
 Investment and Feasibility Studies
 Demographic and Economic Outlook
SUBSCRIPTION MODEL
Databases Offered
 Chemicals and Minerals Online Database

 Automotive Industry Database
 Oil and Gas Infrastructure Across Value Chain Database
 Semiconductors and Electronics Database
 Healthcare and Pharmaceuticals Database
Our annual subscription model is aimed at providing solutions to all research requirements, on a
single platform.
The model is comprised of four aspects, as mentioned below –
1) Access to 12 daily updated proprietary databases that give clues on new developments,
opportunities and industry movements
2) Access to 4000+ of research reports analyzing past events, current trends and providing future
outlook (country level market intelligence reports, company profiles, Investment prospect reports,
Analytical research works comprising technology, price forecasts, competition, strategies and
government stances)
3) Free custom work for special requirements
Our unique subscription model that caters end to end data and analysis requirements of clients on a
single platform is a key offering from MARRA research. Subscription model with entire data and
analysis of specific industry on a single platform priced at reasonable cost is attracting wide range
of customers.
Our uniqueness stems from the collection of passionate young analytical minds and real time industry
experts. These people see trends and issues in the market and evaluate projects for expansion and
investment. We excel in identifying true potential of any oil and gas project based on a range of
parameters.
Our daily updated databases, in-house modeling tools and unique research methodology ensures
bespoke research that helps you stand out among competition with clear understanding and outlook
of the industry.
Contact Information
North America
Connecticut
360 Tolland Turnpike, Suite 2D Manchester, CT, USA 06042, US
Texas
1500 Corporate Circle, Suite # 17, Southlake, Tx-76092, US
Asia-Pacific
Lakshmi SaiDamam, Plot No: 188/29, Hi-Tech City, Hyderabad, India-500081.
Email: sales@oganalysis.com; Telephone: +91-7337-01-3757; Website-www.oganalysis.com;
This report is solely intended for the buyer and no part of it may be reproduced, stored or
transmitted in any form by any means, electronic, mechanical, photocopying, recording, or otherwise
without the prior written permission of OGAnalysis.
All rights reserved.

Sample - Global in Vitro Diagnostics (IVD) Market To 2025 PDF

Caricato da

Informazioni sul documento

Titolo originale

Copyright

Formati disponibili

Condividi questo documento

Condividi o incorpora il documento

Opzioni di condivisione

Hai trovato utile questo documento?

Questo contenuto è inappropriato?

Copyright:

Formati disponibili

Sample - Global in Vitro Diagnostics (IVD) Market To 2025 PDF

Caricato da

Copyright:

Formati disponibili

GLOBAL IN VITRO DIAGNOSTICS

(IVD) MARKET TO 2025

Growth Opportunities, Competition, Trends And

GLOBAL IN VITRO DIAGNOSTICS (IVD)

- BY Test Type (Immunoassays, Blood

- By Application (Infectious disease,

-By End User Industry (Hospital, Clinics, Point

1. GLOBALIN VITRO DIAGNOSTICS (IVD) INDUSTRY

Instruments Blood Glucose

GLOBAL IN VITRO DIAGNOSTICS (IVD)

By Application By End User

Drug Testing Others

GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET

North Middle East South

USA Germany China Middle East Argentina

Canada UK South Korea Africa Brazil

Mexico France Japan Rest of South

Global In Vitro Diagnostics (IVD) Market Valued at $52.9

Market is Outlook to witness 5.43% CAGR Growth over

Asia Pacific stood the Most Attractive Market Worldwide

India market will Surpass XX market driven by growth in

Increasing number of Companies opting for Inorganic

Key Trend Set to the Shape the Future of Industry

Widening Scope of End User Markets with New uses in

Top performing Type as of 2018 is Infectious Diseases

.Figure 1: Global In Vitro Diagnostics (IVD) Company Market Share (%)

Industry Attractiveness Index – 2018(Sample Graph)

TEXT REDACTED IN SAMPLE VIEW

Figure 2: Global IVD InstrumentsMarket Value Outlook, $Million, 2017-2025

TEXT REDACTED IN SAMPLE VIEW

Figure 3: Global IVD ReagentsMarket Value Outlook, $Million, 2017-2025

TEXT REDACTED IN SAMPLE VIEW

TEXT REDACTED IN SAMPLE VIEW

Figure 4: Global Immunoassays In Vitro Diagnostics (IVD)Market Value Outlook, $Million,

TEXT REDACTED IN SAMPLE VIEW

TEXT REDACTED IN SAMPLE VIEW

TEXT REDACTED IN SAMPLE VIEW

TEXT REDACTED IN SAMPLE VIEW

Bubble size indicates the 2018 market value ($millions)

Key factors shaping the future of North American demand include-

TEXT REDACTED IN SAMPLE VIEW

TEXT REDACTED IN SAMPLE VIEW

TEXT REDACTED IN SAMPLE VIEW

Companies analyzed in this report include-

Abbott Laboratories, Inc.

Thermo Fisher Scientific

Becton, Dickinson and Company

Ortho Clinical Diagnostics

TEXT REDACTED IN SAMPLE VIEW

Roche Diagnostics -Key Indicators, $Million

Parameter(In $millions) Value

Roche Diagnostics -Key Ratios

Parameter Dec-2017 Dec-2016 Dec-2015 Dec-2014

Mergers & Acquisitions

Other Key Developments

PRODUCTS AND SERVICES OFFERED

 Country and Regional Market Intelligence Reports

 Chemicals and Minerals Online Database

The model is comprised of four aspects, as mentioned below –

3) Free custom work for special requirements

360 Tolland Turnpike, Suite 2D Manchester, CT, USA 06042, US

1500 Corporate Circle, Suite # 17, Southlake, Tx-76092, US

Lakshmi SaiDamam, Plot No: 188/29, Hi-Tech City, Hyderabad, India-500081.